Search
Close this search box.

July 4, 2024

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

HH Shaikh Khalid bin Hamad emphasises Bahrain’s belief in youth

His Highness Shaikh Khalid bin Hamad Al Khalifa, His Highness Shaikh Khalid bin Hamad Al Khalifa, Supreme Council for Youth and Sports First Deputy Chairman, General Sports Authority (GSA) and Bahrain Olympic Committee President (BOC), affirmed that B…

Speaker congratulates Algeria on Independence Day

Ahmed bin Salman Al Musallam, the Speaker of the Council of Representatives, sent cables of congratulations to Ibrahim Boughali, Speaker of the National People’s Assembly of Algeria, and Salah Goudjil, Speaker of the Council of the Nation of Algeria, …